Definition and epidemiology of late presentation in Europe

Margaret Johnson, Caroline Sabin, Enrico Girardi

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Accurate estimates of HIV prevalence in Europe are hampered by incomplete reporting of new HIV diagnoses. Defining the epidemiology of late presentation is even more challenging. In Europe, the most common definitions of late presentation are based on CD4+ T-cell counts, but there is little consistency among definitions. Thus, estimates of the incidence of late presentation vary widely between studies and across Europe, making comparative analysis difficult. Late presentation has been observed to be common in all demographic groups, but certain factors indicate greater risk for late presentation, including intravenous drug use, older age, foreign birth and non-White ethnicity. Standardizing the definition of late presentation will facilitate understanding, clinical research and, ultimately, effective treatment of late-presenting patients.

Original languageEnglish
Pages (from-to)3-8
Number of pages6
JournalAntiviral Therapy
Volume15
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 2010

Fingerprint

Epidemiology
HIV
CD4 Lymphocyte Count
Demography
Parturition
T-Lymphocytes
Incidence
Research
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Definition and epidemiology of late presentation in Europe. / Johnson, Margaret; Sabin, Caroline; Girardi, Enrico.

In: Antiviral Therapy, Vol. 15, No. SUPPL. 1, 2010, p. 3-8.

Research output: Contribution to journalArticle

Johnson, Margaret ; Sabin, Caroline ; Girardi, Enrico. / Definition and epidemiology of late presentation in Europe. In: Antiviral Therapy. 2010 ; Vol. 15, No. SUPPL. 1. pp. 3-8.
@article{13cbc43337d24b65999f5ed1783594b4,
title = "Definition and epidemiology of late presentation in Europe",
abstract = "Accurate estimates of HIV prevalence in Europe are hampered by incomplete reporting of new HIV diagnoses. Defining the epidemiology of late presentation is even more challenging. In Europe, the most common definitions of late presentation are based on CD4+ T-cell counts, but there is little consistency among definitions. Thus, estimates of the incidence of late presentation vary widely between studies and across Europe, making comparative analysis difficult. Late presentation has been observed to be common in all demographic groups, but certain factors indicate greater risk for late presentation, including intravenous drug use, older age, foreign birth and non-White ethnicity. Standardizing the definition of late presentation will facilitate understanding, clinical research and, ultimately, effective treatment of late-presenting patients.",
author = "Margaret Johnson and Caroline Sabin and Enrico Girardi",
year = "2010",
doi = "10.3851/IMP1522",
language = "English",
volume = "15",
pages = "3--8",
journal = "Antiviral Therapy",
issn = "1359-6535",
publisher = "International Medical Press Ltd",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Definition and epidemiology of late presentation in Europe

AU - Johnson, Margaret

AU - Sabin, Caroline

AU - Girardi, Enrico

PY - 2010

Y1 - 2010

N2 - Accurate estimates of HIV prevalence in Europe are hampered by incomplete reporting of new HIV diagnoses. Defining the epidemiology of late presentation is even more challenging. In Europe, the most common definitions of late presentation are based on CD4+ T-cell counts, but there is little consistency among definitions. Thus, estimates of the incidence of late presentation vary widely between studies and across Europe, making comparative analysis difficult. Late presentation has been observed to be common in all demographic groups, but certain factors indicate greater risk for late presentation, including intravenous drug use, older age, foreign birth and non-White ethnicity. Standardizing the definition of late presentation will facilitate understanding, clinical research and, ultimately, effective treatment of late-presenting patients.

AB - Accurate estimates of HIV prevalence in Europe are hampered by incomplete reporting of new HIV diagnoses. Defining the epidemiology of late presentation is even more challenging. In Europe, the most common definitions of late presentation are based on CD4+ T-cell counts, but there is little consistency among definitions. Thus, estimates of the incidence of late presentation vary widely between studies and across Europe, making comparative analysis difficult. Late presentation has been observed to be common in all demographic groups, but certain factors indicate greater risk for late presentation, including intravenous drug use, older age, foreign birth and non-White ethnicity. Standardizing the definition of late presentation will facilitate understanding, clinical research and, ultimately, effective treatment of late-presenting patients.

UR - http://www.scopus.com/inward/record.url?scp=77952042483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952042483&partnerID=8YFLogxK

U2 - 10.3851/IMP1522

DO - 10.3851/IMP1522

M3 - Article

VL - 15

SP - 3

EP - 8

JO - Antiviral Therapy

JF - Antiviral Therapy

SN - 1359-6535

IS - SUPPL. 1

ER -